Cargando…
Drug-development, dose-selection, rational combinations from bench-to-bedside: are there any lessons worth revisiting?
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8169070/ https://www.ncbi.nlm.nih.gov/pubmed/34084277 http://dx.doi.org/10.18632/oncotarget.27931 |
| _version_ | 1783701984824524800 |
|---|---|
| author | Bridges, Alexander J. Mehta, Ranjit K. Shukla, Sushmita Schipper, Matthew J. Lawrence, Theodore S. Nyati, Mukesh K. |
| author_facet | Bridges, Alexander J. Mehta, Ranjit K. Shukla, Sushmita Schipper, Matthew J. Lawrence, Theodore S. Nyati, Mukesh K. |
| author_sort | Bridges, Alexander J. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8169070 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Impact Journals LLC |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-81690702021-06-02 Drug-development, dose-selection, rational combinations from bench-to-bedside: are there any lessons worth revisiting? Bridges, Alexander J. Mehta, Ranjit K. Shukla, Sushmita Schipper, Matthew J. Lawrence, Theodore S. Nyati, Mukesh K. Oncotarget Editorial Impact Journals LLC 2021-05-25 /pmc/articles/PMC8169070/ /pubmed/34084277 http://dx.doi.org/10.18632/oncotarget.27931 Text en Copyright: © 2021 Bridges et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/3.0/) (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
| spellingShingle | Editorial Bridges, Alexander J. Mehta, Ranjit K. Shukla, Sushmita Schipper, Matthew J. Lawrence, Theodore S. Nyati, Mukesh K. Drug-development, dose-selection, rational combinations from bench-to-bedside: are there any lessons worth revisiting? |
| title | Drug-development, dose-selection, rational combinations from bench-to-bedside: are there any lessons worth revisiting? |
| title_full | Drug-development, dose-selection, rational combinations from bench-to-bedside: are there any lessons worth revisiting? |
| title_fullStr | Drug-development, dose-selection, rational combinations from bench-to-bedside: are there any lessons worth revisiting? |
| title_full_unstemmed | Drug-development, dose-selection, rational combinations from bench-to-bedside: are there any lessons worth revisiting? |
| title_short | Drug-development, dose-selection, rational combinations from bench-to-bedside: are there any lessons worth revisiting? |
| title_sort | drug-development, dose-selection, rational combinations from bench-to-bedside: are there any lessons worth revisiting? |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8169070/ https://www.ncbi.nlm.nih.gov/pubmed/34084277 http://dx.doi.org/10.18632/oncotarget.27931 |
| work_keys_str_mv | AT bridgesalexanderj drugdevelopmentdoseselectionrationalcombinationsfrombenchtobedsidearethereanylessonsworthrevisiting AT mehtaranjitk drugdevelopmentdoseselectionrationalcombinationsfrombenchtobedsidearethereanylessonsworthrevisiting AT shuklasushmita drugdevelopmentdoseselectionrationalcombinationsfrombenchtobedsidearethereanylessonsworthrevisiting AT schippermatthewj drugdevelopmentdoseselectionrationalcombinationsfrombenchtobedsidearethereanylessonsworthrevisiting AT lawrencetheodores drugdevelopmentdoseselectionrationalcombinationsfrombenchtobedsidearethereanylessonsworthrevisiting AT nyatimukeshk drugdevelopmentdoseselectionrationalcombinationsfrombenchtobedsidearethereanylessonsworthrevisiting |